Xiaoying Sun

2.4k total citations · 2 hit papers
50 papers, 1.6k citations indexed

About

Xiaoying Sun is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Xiaoying Sun has authored 50 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 18 papers in Pulmonary and Respiratory Medicine and 15 papers in Cancer Research. Recurrent topics in Xiaoying Sun's work include Cancer Genomics and Diagnostics (9 papers), Lung Cancer Treatments and Mutations (6 papers) and Cancer Cells and Metastasis (5 papers). Xiaoying Sun is often cited by papers focused on Cancer Genomics and Diagnostics (9 papers), Lung Cancer Treatments and Mutations (6 papers) and Cancer Cells and Metastasis (5 papers). Xiaoying Sun collaborates with scholars based in China, United States and Thailand. Xiaoying Sun's co-authors include Fei Ma, Binghe Xu, Hongnan Mo, Zhihua Liu, Baolin Liu, Ranran Gao, Hongyan Chen, Yuanyuan Zhang, Qing Chang and Yong Wang and has published in prestigious journals such as Nature Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Xiaoying Sun

50 papers receiving 1.6k citations

Hit Papers

Single-cell analyses reveal key immune cell subsets assoc... 2021 2026 2022 2024 2021 2025 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Single-cell analyses reveal key immune cell subsets associated with response to PD-L1 blockade in triple-negative breast cancer
    2021 434 citations Yuanyuan Zhang, Hongyan Chen et al. Cancer Cell profile →
  2. Distinct cellular mechanisms underlie chemotherapies and PD-L1 blockade combinations in triple-negative breast cancer
    2025 25 citations Yuanyuan Zhang, Hongyan Chen et al. Cancer Cell profile →

Peers

Xiaoying Sun
Hannes Neuwirt Austria
Antonino Grassadonia Italy
Tonya C. Walser United States
Jürgen R. Fischer Germany
Kathleen D. Whitney United States
Klaus Baumann Germany
Dapeng Wu China
Bingyin Shi China
Sachin Gopalkrishna Pai United States
Hans-Juergen Schulten Saudi Arabia
Hannes Neuwirt Austria
Xiaoying Sun
Citations per year, relative to Xiaoying Sun Xiaoying Sun (= 1×) peers Hannes Neuwirt

Countries citing papers authored by Xiaoying Sun

Since Specialization
Citations

This map shows the geographic impact of Xiaoying Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoying Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoying Sun more than expected).

Fields of papers citing papers by Xiaoying Sun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoying Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoying Sun. The network helps show where Xiaoying Sun may publish in the future.

Co-authorship network of co-authors of Xiaoying Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoying Sun. A scholar is included among the top collaborators of Xiaoying Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoying Sun. Xiaoying Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lan, Bo, Jiayu Wang, Qiao Li, et al.. (2025). The ideal strategies of antibody‒drug conjugate sequential treatment in HER2-expressing metastatic breast cancer: A multi-center real-world study. The Breast. 81. 104470–104470. 3 indexed citations
2.
Zhang, Yuanyuan, Hongyan Chen, Hongnan Mo, et al.. (2025). Distinct cellular mechanisms underlie chemotherapies and PD-L1 blockade combinations in triple-negative breast cancer. Cancer Cell. 43(3). 446–463.e7. 25 indexed citations breakdown →
3.
Mo, Hongnan, Yongpei Yu, Xiaoying Sun, et al.. (2024). Metronomic chemotherapy plus anti-PD-1 in metastatic breast cancer: a Bayesian adaptive randomized phase 2 trial. Nature Medicine. 30(9). 2528–2539. 11 indexed citations
4.
Lv, Dan, Bo Lan, Li Zhang, et al.. (2022). Association between depression and anxiety status of breast cancer patients before adjuvant chemotherapy and chemotherapy‐induced adverse events. Cancer Medicine. 12(4). 4794–4800. 8 indexed citations
5.
Sun, Xiaoying, et al.. (2022). The prognostic impact of the immune microenvironment in small-cell neuroendocrine carcinoma of the uterine cervix: PD-L1 and immune cell subtypes. Cancer Cell International. 22(1). 348–348. 11 indexed citations
6.
Lan, Bo, Dan Lv, Xiaoying Sun, et al.. (2022). Genetic Variations in IFNGR1, BDNF and IL-10 May Predict the Susceptibility to Depression and Anxiety in Chinese Women With Breast Cancer. Clinical Breast Cancer. 22(7). 674–680. 7 indexed citations
7.
8.
Wang, Jiao, Liu Liu, Xiaoying Sun, et al.. (2022). Evidence and Potential Mechanism of Action of Lithospermum erythrorhizon and Its Active Components for Psoriasis. Frontiers in Pharmacology. 13. 781850–781850. 19 indexed citations
9.
Zhang, Yuanyuan, Hongyan Chen, Hongnan Mo, et al.. (2021). Single-cell analyses reveal key immune cell subsets associated with response to PD-L1 blockade in triple-negative breast cancer. Cancer Cell. 39(12). 1578–1593.e8. 434 indexed citations breakdown →
10.
Yi, Zongbi, Fei Ma, Guohua Rong, et al.. (2021). The molecular tumor burden index as a response evaluation criterion in breast cancer. Signal Transduction and Targeted Therapy. 6(1). 251–251. 31 indexed citations
11.
Zhang, Shiwen, Rongzhen Luo, Xiaoying Sun, et al.. (2021). Co-expression of SOX2 and HR-HPV RISH predicts poor prognosis in small cell neuroendocrine carcinoma of the uterine cervix. BMC Cancer. 21(1). 332–332. 4 indexed citations
12.
Mo, Hongnan, Xiaobing Wang, Fei Ma, et al.. (2020). Genome-wide chromosomal instability by cell-free DNA sequencing predicts survival in patients with metastatic breast cancer. The Breast. 53. 111–118. 10 indexed citations
13.
14.
Li, Han, Weijing Zhang, Ming Yan, et al.. (2019). Nucleolar and spindle associated protein 1 promotes metastasis of cervical carcinoma cells by activating Wnt/β-catenin signaling. Journal of Experimental & Clinical Cancer Research. 38(1). 33–33. 69 indexed citations
15.
Liu, Liu, Ying Luo, Mi Zhou, et al.. (2019). Tripterygium agents for the treatment of atopic eczema: A Bayesian analysis of randomized controlled trials. Phytomedicine. 59. 152914–152914. 16 indexed citations
16.
Zhang, Weijing, et al.. (2018). Overexpression of kinesin family member 20A is associated with unfavorable clinical outcome and tumor progression in epithelial ovarian cancer. Cancer Management and Research. Volume 10. 3433–3450. 25 indexed citations
17.
Sun, Xiaoying, et al.. (2018). “The Therapy of Elimination First” for Early Acute Mastitis: A Systematic Review and Meta‐Analysis. Evidence-based Complementary and Alternative Medicine. 2018(1). 8059256–8059256. 2 indexed citations
18.
Yi, Zongbi, Fei Ma, Chunxiao Li, et al.. (2017). Landscape of somatic mutations in different subtypes of advanced breast cancer with circulating tumor DNA analysis. Scientific Reports. 7(1). 5995–5995. 24 indexed citations
19.
Zhang, Weijing, Weiling He, Teng Hou, et al.. (2015). Upregulation of centrosomal protein 55 is associated with unfavorable prognosis and tumor invasion in epithelial ovarian carcinoma. Tumor Biology. 37(5). 6239–6254. 26 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hannes Neuwirt Breakdown of academic impact, for papers by Antonino Grassadonia Breakdown of academic impact, for papers by Tonya C. Walser Breakdown of academic impact, for papers by Jürgen R. Fischer Breakdown of academic impact, for papers by Kathleen D. Whitney Breakdown of academic impact, for papers by Klaus Baumann Breakdown of academic impact, for papers by Dapeng Wu Breakdown of academic impact, for papers by Bingyin Shi Breakdown of academic impact, for papers by Sachin Gopalkrishna Pai Breakdown of academic impact, for papers by Hans-Juergen Schulten
Rankless by CCL
2026